A multiplex allele-specific real-time PCR assay for screening of ESR1 mutations in metastatic breast cancer

被引：15

作者：

Wang, Ting ^{[1
]}

Liu, Jin-Hui ^{[1
]}

Zhang, Jie ^{[1
]}

Wang, Le ^{[1
,2
]}

Chen, Chao ^{[1
]}

Dai, Peng-Gao ^{[1
]}

机构：

[1] NW Univ Xian, Sch Life Sci, Natl Engn Res Ctr Miniaturized Detect Syst, Xian 710069, Peoples R China

[2] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 1, Xian 710049, Peoples R China

来源：

EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2015年 / 98卷 / 02期

基金：

中国国家自然科学基金;

关键词：

ESR1; Multiplex allele-specific PCR; Mutations; Breast cancer; ENDOCRINE RESISTANCE; BRAF; DNA;

D O I：

10.1016/j.yexmp.2015.03.004

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Background: Acquired resistance to endocrine-based therapies occurs in virtually all estrogen receptor-alpha (ER alpha, encoded by ESR1) positive breast cancer patients. The underlying molecular mechanism is attributed to the activating mutations in ESR1. These mutations provide an exciting opportunity for the development of new antagonists that specifically inhibit the mutant proteins. Therefore, accurate detection of ESR1 mutations is of critical importance in clinical practice. Materials and methods: We carried out a single tube, multiplex allele-specific real-time PCR assay for the detection of four ESR1 mutations (Y537S, Y537C, Y537N, and D538G). Results: The assay was found to be highly specific and sensitive. With this assay, as low as 1% mutant DNA template in wild type DNA could be detected. Fifteen DNA samples were prepared from archived formalin-fixed paraffin-embedded metastatic breast cancer biopsies. They were further screened with this assay, and three samples were identified as ESR1 mutant. The results were validated with pyrosequencing and complete concordance was observed between the two assays. Conclusion: The multiplex allele-specific real-time PCR assay provides a rapid and reliable diagnostic tool for accurate detection of ESR1 mutations. This procedure may be used in the clinical treatment of breast cancer. (C) 2015 Elsevier Inc. All rights reserved.

引用

页码：152 / 157

页数：6

共 16 条

[1] Estrogen receptors as therapeutic targets in breast cancer [J].

Ariazi, Eric A. ;

Ariazi, Jennifer L. ;

Cordera, Fernando ;

Jordan, V. Craig .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (03) :181-202

[2] Analytical Performance of a Real-time PCR-based Assay for V600 Mutations in the BRAF Gene, Used as the Companion Diagnostic Test for the Novel BRAF Inhibitor Vemurafenib in Metastatic Melanoma [J].

Halait, Harkanwal ;

DeMartin, Kelli ;

Shah, Sweta ;

Soviero, Stephen ;

Langland, Rachel ;

Cheng, Suzanne ;

Hillman, Grantland ;

Wu, Lin ;

Lawrence, H. Jeffrey .

DIAGNOSTIC MOLECULAR PATHOLOGY, 2012, 21 (01) :1-8

[3] Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF [J].

Lang, Alois H. ;

Drexel, Heinz ;

Geller-Rhomberg, Simone ;

Stark, Nicole ;

Winder, Thomas ;

Geiger, Kathrin ;

Muendlein, Axel .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (01) :23-28

[4] Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved [J].

Lonning, Per Eystein ;

Eikesdal, Hans Petter .

[5] D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer [J].

Merenbakh-Lamin, Keren ;

Ben-Baruch, Noa ;

Yeheskel, Adva ;

Dvir, Addie ;

Soussan-Gutman, Lior ;

Jeselsohn, Rinath ;

Yelensky, Roman ;

Brown, Myles ;

Miller, Vincent A. ;

Sarid, David ;

Rizel, Shulamith ;

Klein, Baruch ;

Rubinek, Tami ;

Wolf, Ido .

CANCER RESEARCH, 2013, 73 (23) :6856-6864

[6] ANALYSIS OF ANY POINT MUTATION IN DNA - THE AMPLIFICATION REFRACTORY MUTATION SYSTEM (ARMS) [J].

NEWTON, CR ;

GRAHAM, A ;

HEPTINSTALL, LE ;

POWELL, SJ ;

SUMMERS, C ;

KALSHEKER, N ;

SMITH, JC ;

MARKHAM, AF .

NUCLEIC ACIDS RESEARCH, 1989, 17 (07) :2503-2516

[7] The search for ESR1 mutations in breast cancer [J].

Oesterreich, Steffi ;

Davidson, Nancy E. .

NATURE GENETICS, 2013, 45 (12) :1415-1416

[8] Mechanisms of Endocrine Resistance in Breast Cancer [J].

Osborne, C. Kent ;

Schiff, Rachel .

ANNUAL REVIEW OF MEDICINE, VOL 62, 2011, 2011, 62 :233-247

[9] Pathways to tamoxifen resistance [J].

Riggins, Rebecca B. ;

Schrecengost, Randy S. ;

Guerrero, Michael S. ;

Bouton, Amy H. .

CANCER LETTERS, 2007, 256 (01) :1-24

[10] Activating ESR1 mutations in hormone-resistant metastatic breast cancer [J].

Robinson, Dan R. ;

Wu, Yi-Mi ;

Vats, Pankaj ;

Su, Fengyun ;

Lonigro, Robert J. ;

Cao, Xuhong ;

Kalyana-Sundaram, Shanker ;

Wang, Rui ;

Ning, Yu ;

Hodges, Lynda ;

Gursky, Amy ;

Siddiqui, Javed ;

Tomlins, Scott A. ;

Roychowdhury, Sameek ;

Pienta, Kenneth J. ;

Kim, Scott Y. ;

Roberts, J. Scott ;

Rae, James M. ;

Van Poznak, Catherine H. ;

Hayes, Daniel F. ;

Chugh, Rashmi ;

Kunju, Lakshmi P. ;

Talpaz, Moshe ;

Schott, Anne F. ;

Chinnaiyan, Arul M. .

NATURE GENETICS, 2013, 45 (12) :1446-U197

← 1 2 →